AGPAT2 and Cognitive impairment: No mutations are found to be associated with neuronal dysfunction or intellectual impairment, although 10% of BSCL1 subjects (17 families/21 affected subjects) tested by Maldergem et al. showed mild or moderate intellectual impairment [9].